Ipamorelin

[TODO] Hook — ipamorelin as the most selective growth hormone secretagogue, cleanest side effect profile among GHRPs, popular in research protocols

What is Ipamorelin?

• [TODO] Classification — growth hormone releasing peptide (GHRP), pentapeptide
• [TODO] Receptor — ghrelin/GHS-R1a receptor agonist
• [TODO] Key advantage — highly selective; does not significantly raise cortisol, prolactin, or ACTH
• [TODO] Half-life — ~2 hours
• [TODO] Often combined with Mod GRF 1-29 for synergistic GH release

Mechanism of Action

• [TODO] Ghrelin receptor — anterior pituitary, amplifies GHRH signal
• [TODO] Selectivity — minimal appetite stimulation (unlike GHRP-6), no cortisol spike
• [TODO] Pulsatile GH — triggers acute GH pulse similar to natural secretion
• [TODO] Synergy with GHRH — GHRH initiates pulse, GHRP amplifies amplitude

Research Highlights

• [TODO] GH release — dose-dependent GH increase, plateau at ~300mcg
• [TODO] Bone density — increased bone mineral content in animal models
• [TODO] Body composition — lean mass, fat reduction when combined with CJC
• [TODO] Sleep — improved sleep quality via GH pulse optimization

Dosing Protocols (Research Context)

• [TODO] Typical dose — 100-300mcg per administration, subcutaneous
• [TODO] Frequency — 1-3x daily (pre-bed most common)
• [TODO] Combination — 100mcg Ipamorelin + 100mcg Mod GRF 1-29
• [TODO] Fasted state — administer on empty stomach for optimal GH response

Safety & Considerations

• [TODO] Excellent tolerability — cleanest GHRP side effect profile
• [TODO] No cortisol/prolactin — unlike GHRP-2 and GHRP-6
• [TODO] Minimal appetite stimulation — unlike ghrelin and GHRP-6
• [TODO] Water retention — possible at higher doses, mild and transient

Häufig gestellte Fragen

Related Products

[TODO] Link to Ipamorelin product page + Growth Hormone category